Biosynex Nordic ApS: Financial statements 2018
CVR: 38417541
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -35,113 and a net result of DKK -29,443 compared with DKK 664 the year before. Equity in the 2018 report amounted to DKK 21,221. The solvency ratio was 7.5%.
- Gross Profit
- DKK -35,113
- Profit/Loss
- DKK -29,443
- Equity
- DKK 21,221
- Total Assets
- DKK 283,125
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -35 t. | -29 t. | 21 t. | 0 |
| 2017 | 356 t. | 840 | 664 | 51 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of August 30, 2018, Preben Joffe is registered as adm. dir. of Biosynex Nordic ApS.
As of August 30, 2018, Suzanne Flagstad has stepped down as director of Biosynex Nordic ApS.
Biosynex Nordic ApS has published its interim report for the period February 9, 2017 to December 31, 2017.
About Biosynex Nordic ApS
Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.